Proteomics: Current technologies and applications in neurological disorders and toxicology

被引:98
|
作者
Fountoulakis, M [1 ]
机构
[1] F Hoffmann La Roche & Co Ltd, Pharmaceut Res, Genom Technol, CH-4070 Basel, Switzerland
关键词
amino acids; 2-D electrophoresis; neurological disorders; matrix-assisted laser desortpion ionization mass spectrometry; proteomics; toxicology;
D O I
10.1007/s007260170002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteomics is the science that studies the proteins in general and in particular their changes, resulting from various disorders or the effect of external factors, such as toxic agents. It has as goal the detection of novel drug targets, diagnostic markers and the investigation of biological events. Proteomics has emerged the last few years and its major difference from the previously existing protein analytical techniques is that it does not analyze the proteins one by one, but in a possibly automated, large-scale mode. In this article, the state of the art of proteomics in our laboratory is presented, as well as selected applications of proteomics in the study of disorders of the central nervous system and of toxic events.
引用
收藏
页码:363 / 381
页数:19
相关论文
共 50 条
  • [1] Proteomics: Current technologies and applications in neurological disorders and toxicology
    M. Fountoulakis
    Amino Acids, 2001, 21 : 363 - 381
  • [2] Development of proteomics and applications of proteomics in toxicology
    Jung, Woon-Won
    Huh, Yoonee
    Ryu, Jae-Chun
    Lee, Eunil
    Sul, Donggeun
    MOLECULAR & CELLULAR TOXICOLOGY, 2005, 1 (01) : 7 - 12
  • [3] Proteomics: Technologies and Their Applications
    Aslam, Bilal
    Basit, Madiha
    Nisar, Muhammad Atif
    Khurshid, Mohsin
    Rasool, Muhammad Hidayat
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2017, 55 (02) : 182 - 196
  • [4] Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology
    Heijne, Wilbert H. M.
    Kienhuis, Anne S.
    van Ommen, Ben
    Stierum, Rob H.
    Groten, John P.
    EXPERT REVIEW OF PROTEOMICS, 2005, 2 (05) : 767 - 780
  • [5] Limitations of current proteomics technologies
    Garbis, S
    Lubec, G
    Fountoulakis, M
    JOURNAL OF CHROMATOGRAPHY A, 2005, 1077 (01) : 1 - 18
  • [6] Proteomics: new technologies and their applications
    Jain, KK
    DRUG DISCOVERY TODAY, 2001, 6 (09) : 457 - 459
  • [7] What technologies bring in the field of neurological disorders: Current realities and future perspectives
    Benabid, Alim Louis
    Mitrofanis, John
    Chabardes, Stephan
    Garrec, Philippe
    M S-MEDECINE SCIENCES, 2022, 38 (03): : 241 - 242
  • [8] Will current technologies enable dinosaur proteomics?
    Smijkal, Gary B.
    Schweitzer, Mary H.
    EXPERT REVIEW OF PROTEOMICS, 2007, 4 (06) : 695 - 699
  • [9] Current Clinical Applications of Diffusion-Tensor Imaging in Neurological Disorders
    Tae, Woo-Suk
    Ham, Byung-Joo
    Pyun, Sung-Bom
    Kang, Shin-Hyuk
    Kim, Byung-Jo
    JOURNAL OF CLINICAL NEUROLOGY, 2018, 14 (02): : 129 - 140
  • [10] Proteomics: New technologies and clinical applications
    Latterich, Martin
    Abramovitz, Mark
    Leyland-Jones, Brian
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) : 2737 - 2741